These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36946374)

  • 1. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
    Zheng CZ; Yan WW; Luo YL; Wang TL; Shu YB
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5582-5591. PubMed ID: 32495893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
    Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
    Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
    Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
    Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
    Front Immunol; 2020; 11():582737. PubMed ID: 33133102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
    Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
    Front Immunol; 2022; 13():910993. PubMed ID: 36091001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
    Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
    J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction].
    Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ
    Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
    Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
    Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
    Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
    Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Systemic Lupus Erythematosus Disease Activity With Choroidal Thickness.
    Lee I; Gomez AR; Kim AHJ; Coble DW; Marshall B; Shah A; Eisen S; Apte RS; Li T
    J Clin Rheumatol; 2024 Mar; 30(2):e58-e62. PubMed ID: 37798827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.